Executives Should Think Twice Before Accepting Pleas 'Relating to Fraud': The Expansion of Exclusion Under the Park Doctrine

The European Commission’s New Pharmaceutical Strategy for Europe

Biden Administration Issues Rules Requiring Insurer Transparency on Drug Spending, Rebates and Fees: What Manufacturers Need to Know